Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amyloid Beta Protein”

80 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 80 results

Very early researchStudy completedNCT02669225
What this trial is testing

Brain Amyloid- Retention During Wakefulness and Following Emergence From Sleep in Healthy People

Who this might be right for
Normal Physiology
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 22
Early research (Phase 1)Not Yet RecruitingNCT07142278
What this trial is testing

DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau

Who this might be right for
Alzheimer DiseaseAlzheimer Disease (AD)Preclinical Alzheimer's Disease
Nuravax, Inc. 24
Early research (Phase 1)Study completedNCT00287248
What this trial is testing

Assess 123-I IMPY and SPECT Imaging as a Tool to Detect β-Amyloid in the Brain

Who this might be right for
Alzheimer Disease
Institute for Neurodegenerative Disorders 38
Testing effectiveness (Phase 2)Study completedNCT01148498
What this trial is testing

A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 55
Not applicableUnknownNCT05002699
What this trial is testing

Investigating the Impact of Alzheimer's Disease Diagnostics in British Columbia

Who this might be right for
Alzheimer DiseaseDementiaCognitive Impairment+1 more
University of British Columbia 120
Early research (Phase 1)Study completedNCT02033668
What this trial is testing

Pharmacokinetic (PK) Study of GSK933776 in Healthy Volunteers

Who this might be right for
Atrophy, Geographic
GlaxoSmithKline 36
Testing effectiveness (Phase 2)Looking for participantsNCT05774704
What this trial is testing

Curcumin and Retinal Study

Who this might be right for
BioavailabilityGut MicrobiomeSafety
Texas Tech University Health Sciences Center 60
Post-approval studies (Phase 4)Study completedNCT00551161
What this trial is testing

Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Northwell Health 12
Not applicableStudy completedNCT05527288
What this trial is testing

A Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Chinese Population

Who this might be right for
Alzheimer DiseaseDementiaBrain Diseases+6 more
Sinotau Pharmaceutical Group 50
Testing effectiveness (Phase 2)Study completedNCT00750282
What this trial is testing

Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy Volunteers

Who this might be right for
Alzheimer DiseaseAmyloid Beta-Protein
Life Molecular Imaging SA 422
Testing effectiveness (Phase 2)Study completedNCT00088387
What this trial is testing

Effect of Lithium and Divalproex in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
National Institute of Neurological Disorders and Stroke (NINDS) 35
Early research (Phase 1)Study completedNCT01138111
What this trial is testing

Florbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) Patients

Who this might be right for
Alzheimer DiseaseAmyloid Beta-Protein
Life Molecular Imaging SA 45
Early research (Phase 1)Study completedNCT00556660
What this trial is testing

Evaluation of [123I] AV51 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

Who this might be right for
Alzheimer Disease
Institute for Neurodegenerative Disorders 20
Not applicableUnknownNCT02814422
What this trial is testing

Triglyceride-rich Lipoprotein and Development of Dementia

Who this might be right for
Dementia
National Taiwan University Hospital 1,000
Post-approval studies (Phase 4)Study completedNCT02161458
What this trial is testing

Escitalopram Effects on CSF Amyloid Beta

Who this might be right for
Amyloid Beta Protein
University of Pennsylvania 98
Not applicableStudy completedNCT02474251
What this trial is testing

Brain Sleep Clearance of Amyloid-Beta Peptides

Who this might be right for
Obstructive Sleep ApneaAlzheimer's Disease
NYU Langone Health 38
Very early researchStudy completedNCT01217021
What this trial is testing

Safety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558

Who this might be right for
Alzheimer Disease
Institute for Neurodegenerative Disorders 10
Not applicableLooking for participantsNCT06733714
What this trial is testing

Association of Transcranial Alternating Current Stimulation with Digital Cognitive Training for Cognitive Remediation in Older Adults

Who this might be right for
Cognitive DysfunctionAlzheimer DiseaseMild Cognitive Impairment+8 more
Universidade Federal do Rio de Janeiro 40
Early research (Phase 1)Ended earlyNCT00605059
What this trial is testing

Evaluation of [123I] AV94 and SPECT in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

Who this might be right for
Alzheimer Disease
Institute for Neurodegenerative Disorders 3
Early research (Phase 1)Ended earlyNCT00544453
What this trial is testing

Evaluation of [123I] MNI-308 and SPECT as a Marker of Beta-amyloid Protein Deposition in AD Subjects Compared to HC

Who this might be right for
Alzheimer Disease
Molecular NeuroImaging 2
Load More Results